enkephalin, leucine has been researched along with Anxiety Neuroses in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baek, IS; Han, PL; Kim, KS; Krishnan, V; Lee, JK; Lee, KW; Lim, CM; Nestler, EJ | 1 |
Femenía, T; Manzanares, J; Pérez-Rial, S; Urigüen, L | 1 |
Bitsios, P; Hurd, YL; Jacobs, MM; Jutras-Aswad, D; Liu, X; Nomura, Y; Roussos, P; Yiannoulos, G | 1 |
Gabaeva, MV; Kost, NV; Makarenkova, VP; Meshavkin, VK; Sokolov, OIu; Zazulia, AA | 1 |
Andriushenko, AV; Gabaeva, MV; Kost, NV; Miasoedov, NF; Neznamov, GG; Serebriakova, EV; Seredenin, SB; Siranchieva, OA; Siuniakov, SA; Siuniakov, TS; Smulevich, AB; Sokolov, OIu; Telesheva, ES; Zozulia, AA | 1 |
Biederman, J; Faraone, SV; Kagan, J; Kennedy, J; Laird, N; Rosenbaum, JF; Schwarz, A; Slaugenhaupt, SA; Smoller, JW; Snidman, N; Susswein, LS; Tsuang, MT | 1 |
Burrows, GD; Judd, FK; Norman, TR | 1 |
Buiavykh, AG; Ezhov, VA | 1 |
1 trial(s) available for enkephalin, leucine and Anxiety Neuroses
Article | Year |
---|---|
[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].
Topics: Administration, Intranasal; Administration, Oral; Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Biomarkers; Dose-Response Relationship, Drug; Enkephalins; Female; Follow-Up Studies; Humans; Male; Medazepam; Middle Aged; Neurasthenia; Oligopeptides; Psychometrics; Severity of Illness Index; Treatment Outcome | 2008 |
7 other study(ies) available for enkephalin, leucine and Anxiety Neuroses
Article | Year |
---|---|
Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior.
Topics: Adenylyl Cyclases; Animals; Anxiety Disorders; Benzazepines; Cholecystokinin; Dopamine; Dopamine Agonists; Dopamine Antagonists; Down-Regulation; Enkephalins; Gene Expression Regulation, Enzymologic; Isoenzymes; Mice; Mice, Knockout; Narcotic Antagonists; Nucleus Accumbens; Phenanthridines; Protein Precursors; Receptors, Dopamine D1; Receptors, Opioid, kappa; RNA, Small Interfering; Sincalide; Up-Regulation | 2008 |
Prodynorphin gene deletion increased anxiety-like behaviours, impaired the anxiolytic effect of bromazepam and altered GABAA receptor subunits gene expression in the amygdala.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Bromazepam; Enkephalins; Exploratory Behavior; Gene Expression; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Protein Precursors; Receptors, GABA-A; Stress, Physiological | 2011 |
Cannabis-dependence risk relates to synergism between neuroticism and proenkephalin SNPs associated with amygdala gene expression: case-control study.
Topics: Adolescent; Adult; Amygdala; Anxiety Disorders; Case-Control Studies; Endophenotypes; Enkephalins; Female; Humans; Male; Marijuana Abuse; Neuroticism; Polymorphism, Single Nucleotide; Protein Precursors; Young Adult | 2012 |
[Biological mechanisms of the individual variability of the anxiolytic action of opioids].
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain Chemistry; Disease Models, Animal; Enkephalins; Male; Mice; Mice, Inbred BALB C; Naloxone; Narcotic Antagonists; Oligopeptides; Opioid Peptides; Rats; Receptors, Opioid | 2007 |
Genetic association analysis of behavioral inhibition using candidate loci from mouse models.
Topics: Animals; Anxiety Disorders; Behavior, Animal; Child; Child Behavior; Child, Preschool; Enkephalins; Family Health; Glutamate Decarboxylase; Humans; Infant; Infant Behavior; Inhibition, Psychological; Mice; Models, Animal; Nuclear Family; Phenotype; Protein Precursors; Receptor, Adenosine A2A; Receptors, Purinergic P1; Risk Factors | 2001 |
The biological basis of anxiety. An overview.
Topics: Anxiety Disorders; Carbon Dioxide; Dopamine; Enkephalins; gamma-Aminobutyric Acid; Humans; Hyperventilation; Lactates; Lactic Acid; Monoamine Oxidase; Neurotransmitter Agents; Norepinephrine; Panic; Receptors, Adrenergic; Receptors, Dopamine; Receptors, GABA-A; Receptors, Opioid; Serotonin | 1985 |
[Results of the use of dalargin electrophoresis to correct mental disorders in patients with hypertension grades I and II].
Topics: Adult; Anxiety Disorders; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Female; Humans; Hypertension; Iontophoresis; Male; Memory Disorders; Middle Aged; Neurocognitive Disorders; Psychomotor Performance | 1989 |